We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...
Allogene Therapeutics has announced an expanded collaboration with Foresight Diagnostics to develop a minimal residual disease (MRD) assay as a companion diagnostic tool for identifying patients with ...
Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developersCHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document ...
Please provide your email address to receive an email when new articles are posted on . A 14-gene molecular assay may help predict adjuvant chemotherapy benefit in early NSCLC. Patients assigned ...
Fluorescence imaging offers robust, multi-parametric and scalable analysis of cell-level activity in heterogenous populations with excellent spatial and temporal resolution. This seminar will provide ...
The firm has developed a whole-blood mRNA test intended for use as a screening tool in women at elevated risk of breast cancer.
The Cancer Biomarkers Market is poised for robust expansion driven by escalating industry demand, accelerated technological innovation, and expanding clinical adoption. Rising global cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback